The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

The US Food and Drug Administration (FDA) has accepted Novo Nordisk’s new drug application (NDA) submission for the 25 mg ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

ArbliTM is the first FDA-approved ready-to-use oral liquid formulation of losartan, designed for treating hypertension and related conditions in patients over six years old. This novel product ...

Prednisone is a generic drug prescribed for various conditions that involve inflammation. It’s a corticosteroid drug, also called a steroid. Prednisone is a generic prescription drug. It comes ...

Novo Nordisk has filed for U.S. approval of an oral version of its widely popular GLP-1 drug semaglutide, a spokesperson confirmed to BioSpace on Saturday. In an email, the spokesperson said that the ...

While there is not currently a shortage of Ozempic, previous difficulties in supplying this medication have led to some pharmacies offering compounded semaglutide. The Food and Drug Administration ...

When it comes to oral semaglutide, the OASIS-1 trial showed that it led to a 15.1% reduction in body weight. But this was at the highest 50 mg dose and at 68 weeks, meaning a higher dose and duration ...

Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University of Arizona, Tucson, Arizona 85721, United States ...